Picture of Apollomics logo

APLM Apollomics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Apollomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-74.9-94.8-241-173
Depreciation
Amortisation
Non-Cash Items35.548.2191132
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.122.646.54-3.58
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-35.7-43.3-42.8-43.2
Capital Expenditures-10.1-7.55-0.367-0.006
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items12.5-31.429.421.4
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2.33-3929.121.4
Financing Cash Flow Items-4.29-1.26-0.09317.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities126-1.64-0.29421.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash92.2-83.9-14.1-0.619